23rd Annual Symposium of The Protein Society
23rd Annual Symposium of The Protein Society
批准号:
7750412
负责人:
David Eliezer
金额:
$0.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-01 至 2010-06-30
关键词:
AreaBiochemistryBiophysicsBostonCellular biologyCollaborationsCommunicable DiseasesComplexCountryCytoskeletonDevelopmentDiseaseDrug resistanceFosteringGoalsHealthHeart DiseasesHumanIndustryMalignant NeoplasmsMassachusettsMembraneMotionNeurodegenerative DisordersNucleic AcidsOralPlayPostdoctoral FellowProtein DynamicsProteinsResearchResearch PersonnelRoleScheduleSenior ScientistSignal TransductionSocietiesTherapeuticThermodynamicsTranslational ResearchWomanabstractingbasedesigngraduate studentlecturermeetingspostersprogramspublic health relevancesymposiumtherapeutic targettrafficking
中文摘要
描述(由申请人提供):蛋白质学会第23届研讨会将于2009年7月25日至29日在马萨诸塞州波士顿的波士顿万豪科普利广场举行。会议主题是蛋白质运动。会议组织者是西莉亚·希弗(马萨诸塞州大学医学院)和大卫·埃利泽(康奈尔大学威尔医学科尔学院)。两次全体会议将以“动力学和热力学”和“Allostery”为主题。“科学会议将集中在蛋白质设计,运输,折叠,细胞骨架动力学,蛋白质治疗和目标,蛋白质-核酸相互作用的动力学,疾病,耐药性,膜重塑,动态复合物和网络,信号传导,易位和运输。讲师,包括知名高级研究员(例如John Kuriyan(伯克利)、Tom Blundell(剑桥)、Rachel绿色(霍普金斯)、Susan Taylor(加州大学圣地亚哥分校)、Michael Eck(哈佛)等)和初级研究人员,是根据他们杰出的研究项目选择的。此外,该方案是高度多样化的,妇女和其他代表性不足的群体分别占受邀发言人的近三分之一和四分之一。我们的目标是吸引更多的生物医学领域的研究人员,其中蛋白质发挥着重要作用,从基础生物化学和生物物理学到细胞生物学再到人类治疗学。我们的许多专题讨论会涵盖与人类健康和疾病的广泛领域直接相关的主题:神经退行性疾病(折叠和紊乱),癌症(信号传导,细胞骨架动力学,蛋白质核酸相互作用,耐药性和治疗与靶点),传染病(易位和运输,信号传导,膜重塑)和心脏病(贩运,动态复合物和网络,信号)。我们计划有1,300名与会者,包括本科生和研究生,博士后研究员,以及来自美国和其他国家的初级和高级科学家。预计约有300名研究生和200名博士后研究员参加会议。口头会议包括特邀演讲者和推广海报讲座。计划举行15场全体讲座、61位特邀讲者及30场宣传海报讲座。海报会议总共约有400张海报。预计将提交约700份摘要。选择推广海报会谈代表最新的发展,并为本科生和研究生以及博士后研究员提供在会议上发言的机会。
英文摘要
DESCRIPTION (provided by applicant): The 23rd Symposium of The Protein Society will be held July 25-29, 2009 at the Boston Marriott Copley Place in Boston, Massachusetts. The meeting theme is Proteins in Motion. The meeting organizers are Celia Schiffer (Univ of Massachusetts Med Sch) and David Eliezer (Weill Med Coll of Cornell Univ). Two Plenary Sessions will feature the topics of "Dynamics and Thermodynamics" and "Allostery." Scientific sessions will focus on Protein Design, Trafficking, Folding, Cytoskeleton Dynamics, Protein Therapeutics and Targets, Dynamics of Protein-Nucleic Acid Interactions, Disorder, Drug Resistance, Membrane Remodeling, Dynamic Complexes and Networks, Signaling, and Translocation and Transport. Lecturers, including both high profile senior investigators (e.g. John Kuriyan (Berkeley), Tom Blundell (Cambridge), Rachel Green (Hopkins), Susan Taylor (UCSD), Michael Eck (Harvard) etc.) and junior investigators, were chosen on the basis of their outstanding research programs. In addition, the program is highly diverse with women and other underrepresented groups comprising nearly one third and one fourth of the invited speakers, respectively. Our goal is to appeal to an expanded audience of researchers in biomedical fields where proteins play an important role, ranging from basic biochemistry and biophysics to cell biology to human therapeutics. Many of our symposia cover topics with direct relevance to broad areas of human health and disease: neurodegenerative disorders (Folding & Disorder), cancer (Signaling, Cytoskeleton Dynamics, Protein Nucleic Acid Interactions, Drug Resistance, and Therapeutics & Targets), infectious diseases (Translocation & Transport, Signaling, Membrane Remodeling) and heart disease (Trafficking, Dynamic Complexes and Networks, Signaling). We plan for 1,300 attendees, including undergraduate and graduate students, postdoctoral fellows, as well as junior and senior scientists from the U.S. and other countries. Approximately 300 graduate students and 200 postdoctoral fellows are expected to attend the meeting. Oral sessions include invited speakers and promoted poster talks. 15 plenary talks, 61 invited speakers and 30 promoted poster talks are scheduled. The poster sessions total approximately 400 posters. About 700 abstract submissions are anticipated. Promoted poster talks are chosen to represent late-breaking developments and to provide an opportunity for undergraduate and graduate students as well as postdoctoral fellows to speak at the meeting.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Structure and Function of Protein Disorder in Membrane Trafficking and Organization
-
批准号:10609819
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2020
-
负责人:David Eliezer
-
依托单位:
Structure and Function of Protein Disorder in Membrane Trafficking and Organization
-
批准号:10395495
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2020
-
负责人:David Eliezer
-
依托单位:
Structure and Function of Complexin
-
批准号:9751893
-
项目类别:
-
资助金额:$33.12万
-
财政年份:2016
-
负责人:David Eliezer
-
依托单位:
Structure and Function of Complexin
-
批准号:9353435
-
项目类别:
-
资助金额:$33.12万
-
财政年份:2016
-
负责人:David Eliezer
-
依托单位:
Structure and function of alpha-synuclein
-
批准号:9034520
-
项目类别:
-
资助金额:$34.37万
-
财政年份:2015
-
负责人:David Eliezer
-
依托单位:
Structure and function of alpha-synuclein
-
批准号:8786187
-
项目类别:
-
资助金额:$34.38万
-
财政年份:2015
-
负责人:David Eliezer
-
依托单位:
Presentation of Structural Determinants of the 2F5 Neutralization Epitope
-
批准号:7893972
-
项目类别:
-
资助金额:$33.8万
-
财政年份:2009
-
负责人:David Eliezer
-
依托单位:
Presentation of Structural Determinants of the 2F5 Neutralization Epitope
-
批准号:7609151
-
项目类别:
-
资助金额:$21.0万
-
财政年份:2008
-
负责人:David Eliezer
-
依托单位:
Structure and Function of Tau
-
批准号:6984438
-
项目类别:
-
资助金额:$31.0万
-
财政年份:2005
-
负责人:David Eliezer
-
依托单位:
Structure and Function of Tau
-
批准号:7480921
-
项目类别:
-
资助金额:$28.8万
-
财政年份:2005
-
负责人:David Eliezer
-
依托单位:
Structure and Function of Tau
-
批准号:7267631
-
项目类别:
-
资助金额:$29.39万
-
财政年份:2005
-
负责人:David Eliezer
-
依托单位:
Structure and Function of Tau
-
批准号:7097372
-
项目类别:
-
资助金额:$30.27万
-
财政年份:2005
-
负责人:David Eliezer
-
依托单位:
Structure and Function of Alpha-Synuclein
-
批准号:7047811
-
项目类别:
-
资助金额:$30.27万
-
财政年份:2001
-
负责人:David Eliezer
-
依托单位:
Structure and Function of alpha synuclein
-
批准号:6631588
-
项目类别:
-
资助金额:$27.29万
-
财政年份:2001
-
负责人:David Eliezer
-
依托单位:
Structure and Function of alpha synuclein
-
批准号:6320423
-
项目类别:
-
资助金额:$27.29万
-
财政年份:2001
-
负责人:David Eliezer
-
依托单位:
Structure and Function of alpha synuclein
-
批准号:6509982
-
项目类别:
-
资助金额:$27.29万
-
财政年份:2001
-
负责人:David Eliezer
-
依托单位:
Structure and Function of alpha synuclein
-
批准号:6726144
-
项目类别:
-
资助金额:$27.29万
-
财政年份:2001
-
负责人:David Eliezer
-
依托单位:
Structure and Function of Alpha-Synuclein
-
批准号:8236964
-
项目类别:
-
资助金额:$33.3万
-
财政年份:2001
-
负责人:David Eliezer
-
依托单位:
Structure and Function of Alpha-Synuclein
-
批准号:8896186
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2001
-
负责人:David Eliezer
-
依托单位:
Structure and Function of Alpha-Synuclein
-
批准号:7212091
-
项目类别:
-
资助金额:$29.39万
-
财政年份:2001
-
负责人:David Eliezer
-
依托单位:
海外基金